chromogenic substrate spectrozyme fxa (Sekisui Diagnostics)
86
Structured Review
Sekisui Diagnostics
chromogenic substrate spectrozyme fxa
Chromogenic Substrate Spectrozyme Fxa, supplied by Sekisui Diagnostics, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/chromogenic+substrate+spectrozyme+fxa/chromogenic+fxa+spectrozyme+substrate/pm42273738-223-1-5
Average 86 stars, based on 1 article reviews
Chromogenic Substrate Spectrozyme Fxa, supplied by Sekisui Diagnostics, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/chromogenic+substrate+spectrozyme+fxa/chromogenic+fxa+spectrozyme+substrate/pm42273738-223-1-5
Average 86 stars, based on 1 article reviews
chromogenic substrate spectrozyme fxa - by Bioz Stars,
2026-10
86/100 stars
Images
Related Articles
Concentration Assay:Article Title: Discovery and optimization of marstacimab, a human monoclonal antibody targeting tissue factor pathway inhibitor for the treatment of hemophilia A and B. Article Snippet: Human plasma-derived FXa (2 nM; Haematologic Technologies, catalog no. HCXA-0060) was introduced, and the reactions were incubated at 37°C for 30 min. .. The Article Title: Discovery and optimization of marstacimab, a human monoclonal antibody targeting tissue factor pathway inhibitor for the treatment of hemophilia A and B. Article Snippet: Lipidated tissue factor, 1 pM (Innovin, catalog no. 23–044-776) and 1 nM recombinant FVIIa (NovoSeven, Novo Nordisk) were added to the reactions and incubated at 37°C for 5 min. Human FX, 150 nM, (Haematologic Technologies, Inc. catalog no. HCX-0050) was introduced into the reactions. .. The Activity Assay:Article Title: Identification of the integrin-binding site on coagulation factor VIIa required for proangiogenic PAR2 signaling Article Snippet: TF activity was determined by adding 0.5 mL HBS containing human FVIIa and 50 nM FX (Haematologic Technologies, Essex Junction, VT) to adherent cells per 12-well plate at 37°C. .. Activity of FXa was measured in 0.1M EDTA-quenched samples with the Purification:Article Title: Platelet-targeted dual pathway antithrombotic inhibits thrombosis with preserved hemostasis Article Snippet: .. Purified TAP fusion constructs were characterized for their ability to inhibit FXa in solution using Article Title: Platelet-targeted thromboprophylaxis with a human serum albumin fusion drug: Preventing thrombosis and reducing cardiac ischemia/reperfusion injurywithout bleeding complications Article Snippet: .. The inhibition of FXa by the purified proteins was determined using the Construct:Article Title: Platelet-targeted dual pathway antithrombotic inhibits thrombosis with preserved hemostasis Article Snippet: .. Purified TAP fusion constructs were characterized for their ability to inhibit FXa in solution using Inhibition:Article Title: Platelet-targeted thromboprophylaxis with a human serum albumin fusion drug: Preventing thrombosis and reducing cardiac ischemia/reperfusion injurywithout bleeding complications Article Snippet: .. The inhibition of FXa by the purified proteins was determined using the |